Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Trust MF CIO sees revival in corporate cycle, stays bullish on mid and smallcaps
Mihir Vora, Chief Investment Officer at Trust Mutual Fund, remains bullish on renewable energy, with a preference for solar, and is betting on transmission and distribution companies as well as commercial clean energy suppliers catering to sectors such as data centres.
Nifty trades above 23,950 mark; European market advance
IT, media and realty shares advanced while metal, PSU Bank and pharma shares declined.
Sensex, Nifty close sharply higher: 5 reasons behind today's stock market surge
The Sensex climbed 736 points to close at 76,264, while the Nifty advanced 231 points to 23,854. Both indices, however, ended below their intraday highs. The market's advance was led by index heavyweights Larsen & Toubro, Reliance Industries, Mahindra & Mahindra and Maruti Suzuki.
Stocks to buy or sell: Osho Krishan of Angel One suggests buying Nestle India, FACT shares to buy - 11 June - Mint
Stocks to buy or sell: Osho Krishan of Angel One suggests buying Nestle India, FACT shares to buy - 11 JuneMint
Most analysts tracking this Metal stock are bearish, but the one 'bull' sees 28% upside
Beyond immediate market fluctuations, NALCO continues to be identified as a "clean" proxy to play the aluminium and alumina theme. The brokerage has valued the stock at 5.1 times Enterprise value to EBITDA, which, according to HSBC, is attractive.
J B Chemicals & Pharmaceuticals Ltd soars 1.56%
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2206.6, up 1.56% on the day as on 12:49 IST on the NSE. The stock is up 32.31% in last one year as compared to a 7.57% spurt in NIFTY and a 10.6% spurt in the Nifty Pharma index.
Mid and smallcaps get the money as Nifty lags
Investors are increasingly bullish on mid and small-cap stocks, reflecting a notable shift in market sentiment. The Advance-Decline Ratio has shown resilience for the past two months, leading to record highs in midcap and smallcap indices. Meanwhile, large-cap stocks are grappling with foreign selling pressure, suggesting that mid and small caps may continue to shine in the near future.
Haleon to invest Rs 2,000 crore to set up first India plant
Haleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fast-growing consumer healthcare market. The plant will produce oral-health products, including Sensodyne. It aims to reach one billion more consumers by 2030, with 300 million in India. The facility will also cater to export markets.
Smart money move: Why Groww MF's equity chief is betting on multicap strategies
Anupam Tiwari of Groww Mutual Fund warns of a potential oil shock. He believes a multicap strategy combined with bottom-up investing is suitable for current market conditions. Valuations in mid and small caps have improved, making active stock picking more viable. Tiwari highlights opportunities in financials, industrials, autos, and specialty chemicals.
ACME Solar Shares Jump After Raising Rs 2800 crore through QIP; Seen 65% Surge In Six Months
Key investors who have participated in the QIP included Nippon India Mutual Fund, HDFC Mutual Fund, SBI Mutual Fund, ICICI Prudential Mutual Fund, Kotak Mutual Fund, and SBI Life Insurance, among others.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty extends losses to 200 points; Lenskart in focus
Sensex Today | Stock Market LIVE Updates: The bulls may take comfort from the fact that all recent selling has seen a reversal around this 23,250 - 23,350 range. A break of that level risks further downside for the index. Same is the case with the Nifty Bank, which had another 1,000-point range trading day on Monday.
Sensex falls over 500 points, Nifty ends below 23,400; banks, autos drag markets
The Sensex fell 508 points to close at 74,267, while the Nifty declined 165 points to settle at 23,383, slipping below the 23,400 mark. Market breadth remained weak, with declines outpacing advances and the NSE advance-decline ratio standing at 1:2.